Ketamine use: a review.
暂无分享,去创建一个
[1] J. Krystal,et al. Characterization of the Interactive Effects of Glycine and D-Cycloserine in Men: Further Evidence for Enhanced NMDA Receptor Function Associated with Human Alcohol Dependence , 2011, Neuropsychopharmacology.
[2] J. Persson. Wherefore ketamine? , 2010, Current opinion in anaesthesiology.
[3] J. Bloom,et al. Longitudinal trajectories of ketamine use among young injection drug users. , 2010, The International journal on drug policy.
[4] Wei Hao,et al. Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. , 2010, Brain : a journal of neurology.
[5] S. Ng,et al. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. , 2010, Hong Kong medical journal = Xianggang yi xue za zhi.
[6] D. Charney,et al. Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression , 2010, Biological Psychiatry.
[7] Leslie Muetzelfeldt,et al. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. , 2010, Addiction.
[8] J. Oxley,et al. Ketamine cystitis as a mimic of carcinoma in situ , 2009, Histopathology.
[9] R. Hese,et al. [A case of ketamine dependence]. , 2009, Psychiatria polska.
[10] T. Abel,et al. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials , 2009, Neurobiology of Disease.
[11] N. Iacovidou,et al. Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug , 2009, Journal of clinical pharmacology.
[12] A. Loepke,et al. General anesthetics and the developing brain , 2009, Current opinion in anaesthesiology.
[13] S. Ng,et al. Dilated common bile ducts in ketamine abusers. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.
[14] P. Lai,et al. Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.
[15] P. Dargan,et al. Epidemiology of Recreational Drug Toxicity in a Nightclub Environment , 2009, Substance use & misuse.
[16] Leslie Muetzelfeldt,et al. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. , 2009, Addiction.
[17] C. Man,et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? , 2008, BJU international.
[18] D. Gillatt,et al. THE DESTRUCTION OF THE LOWER URINARY TRACT BY KETAMINE ABUSE: A NEW SYNDROME? , 2008, BJU international.
[19] G. Dureja,et al. Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury , 2008, Journal of Brachial Plexus and Peripheral Nerve Injury.
[20] D. Gillatt,et al. Consider ketamine misuse in patients with urinary symptoms. , 2008, The Practitioner.
[21] J. Wiley,et al. PRECLINICAL STUDY: Age‐dependent differences in sensitivity and sensitization to cannabinoids and ‘club drugs’ in male adolescent and adult rats , 2008, Addiction biology.
[22] Sunjeev K Kamboj,et al. Journey through the K-hole: phenomenological aspects of ketamine use. , 2008, Drug and alcohol dependence.
[23] F. Measham,et al. It's the most fun you can have for twenty quid: Meanings, Motivations and Consequences of British Ketamine Use. , 2008 .
[24] M. Grégoire,et al. A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007). , 2008, Urology.
[25] N. Kolhe,et al. Obstructive nephropathy and kidney injury associated with ketamine abuse , 2008, NDT plus.
[26] T. Tonia,et al. Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). , 2008, Journal of clinical psychopharmacology.
[27] K. A. Trujillo,et al. Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use , 2008, Biological Psychiatry.
[28] C. Morgan,et al. Attentional bias to incentive stimuli in frequent ketamine users , 2008, Psychological Medicine.
[29] C. Griffin,et al. Ketamine: The Divisive Dissociative. A Discourse Analysis of the Constructions of Ketamine by Participants of a Free Party (Rave) Scene , 2008 .
[30] F. Measham,et al. “It's the most fun you can have for twenty quid”: Motivations, Consequences and Meanings of British Ketamine Use , 2008 .
[31] R. Newcombe. Ketamine Case Study: The Phenomenology of a Ketamine Experience , 2008 .
[32] R. Vanholder,et al. Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies , 2007, NDT plus.
[33] P. Meyer,et al. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists , 2007, Psychopharmacology.
[34] B. K. Cheung,et al. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine. , 2007, Forensic science international.
[35] E. Rabiner. Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen? , 2007, Journal of psychopharmacology.
[36] J. Krystal. Ketamine and the potential role for rapid-acting antidepressant medications. , 2007, Swiss medical weekly.
[37] C. Blakemore,et al. Development of a rational scale to assess the harm of drugs of potential misuse , 2007, The Lancet.
[38] C. Streutker,et al. Ketamine-associated ulcerative cystitis: a new clinical entity. , 2004, Urology.
[39] A. Winstock,et al. 5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users , 2006, European Addiction Research.
[40] R. Griffiths,et al. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. , 2006, Experimental and clinical psychopharmacology.
[41] C. Morgan,et al. Acute and chronic effects of ketamine upon human memory: a review , 2006, Psychopharmacology.
[42] D. G. Critchlow. A case of ketamine dependence with discontinuation symptoms. , 2006, Addiction.
[43] J. Krystal,et al. Greater vulnerability to the amnestic effects of ketamine in males , 2006, Psychopharmacology.
[44] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[45] Garry D. Honey,et al. Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits , 2006, Trends in Cognitive Sciences.
[46] B. Brandner,et al. Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users , 2006, Biological Psychiatry.
[47] W. Darrow,et al. Risky sexual behaviors associated with recreational drug use among men who have sex with men in an international resort area: Challenges and opportunities , 2005, Journal of Urban Health.
[48] C. Griffin,et al. Ketamine: The divisive dissociative , 2006 .
[49] Mark Slifstein,et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. , 2005, The American journal of psychiatry.
[50] E. Nestler. Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.
[51] M. Sullivan,et al. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. , 2005, The journal of pain : official journal of the American Pain Society.
[52] K. Shelton. Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice. , 2004, Alcohol.
[53] A. Becker,et al. Increased neurogenesis in a rat ketamine model of schizophrenia , 2004, Biological Psychiatry.
[54] R. Gable. Acute Toxic Effects of Club Drugs , 2004, Journal of psychoactive drugs.
[55] Edward J Gracely,et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. , 2004, Pain medicine.
[56] K. Marquis,et al. Effects of fixed ratio size and dose on phencyclidine self-administration by rats , 2004, Psychopharmacology.
[57] C. Morgan,et al. Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study , 2003, Psychopharmacology.
[58] H. Schroeder,et al. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[59] J. Copeland,et al. Patterns of use and harms associated with non-medical ketamine use. , 2003, Drug and alcohol dependence.
[60] D. Lim,et al. Ketamine associated psychedelic effects and dependence. , 2003, Singapore medical journal.
[61] H. Pal,et al. Ketamine dependence. , 2002, Anaesthesia and intensive care.
[62] S R Hursh,et al. Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. , 2002, The Journal of pharmacology and experimental therapeutics.
[63] J. Arditti,et al. [Ketamine--dreams and realities]. , 2002, Acta clinica Belgica.
[64] I. Ben-Shlomo,et al. Intravenous midazolam significantly enhances the lethal effect of thiopental but not that of ketamine in mice. , 2001, Pharmacological research.
[65] C. E. Stewart. Ketamine as a street drug. , 2001, Emergency medical services.
[66] H. Curran,et al. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. , 2001, Addiction.
[67] Patrick M. O'Malley,et al. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .
[68] K. Jansen,et al. A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences , 2000, Journal of psychoactive drugs.
[69] M. Abdel‐Rahman,et al. Teratogenic effect of ketamine and cocaine in CF-1 mice. , 2000, Teratology.
[70] C. Morgan,et al. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. , 2000, Addiction.
[71] John H Krystal,et al. Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.
[72] M. Tsuda,et al. Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. , 2000, Life sciences.
[73] S. Rothrock,et al. Inadvertent ketamine overdose in children: clinical manifestations and outcome. , 1999, Annals of emergency medicine.
[74] J. Bostwick,et al. Ketamine dependence in anesthesia providers. , 1999, Psychosomatics.
[75] D. Cyril D’Souza,et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.
[76] M. Tsuda,et al. Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. , 1999, Life sciences.
[77] J. Krystal,et al. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. , 1998, Archives of general psychiatry.
[78] B. Rocha,et al. Discriminative stimulus effects of diazepam, ketamine and their mixture: ethanol substitution patterns , 1998, Behavioural pharmacology.
[79] N. Volkow,et al. Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects , 1998, Neuropsychopharmacology.
[80] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[81] Bita Moghaddam,et al. Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.
[82] E. Krupitsky,et al. Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. , 1997, Journal of psychoactive drugs.
[83] F. Vollenweider,et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.
[84] A. Malhotra,et al. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.
[85] D. Shewan,et al. Illicit use of ketamine in Scotland. , 1996, Journal of psychoactive drugs.
[86] A. Percy,et al. The 1996 British Crime Survey: England and Wales , 1996 .
[87] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[88] D. Fujikawa. Neuroprotective Effect of Ketamine Administered After Status Epilepticus Onset , 1995, Epilepsia.
[89] Hurt Ph,et al. A case of ketamine dependence. , 1994 .
[90] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[91] E. Ritchie,et al. A case of ketamine dependence. , 1994, The American journal of psychiatry.
[92] K. Berridge,et al. The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.
[93] O. Paulsen,et al. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[94] K. Jansen. Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.
[95] T. Hilden,et al. The psychotropic effect of ketamine. , 1988, Journal of psychoactive drugs.
[96] A. B. Gould,et al. Development of tolerance to ketamine in an infant undergoing repeated anesthesia. , 1981, Anesthesiology.
[97] A. Waterman,et al. THE DEVELOPMENT OF TOLERANCE TO KETAMINE IN RATS AND THE SIGNIFICANCE OF HEPATIC METABOLISM , 1978, British journal of pharmacology.
[98] Siegel Rk. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978 .
[99] Nolan Miller,et al. The Scientist: A Novel Autobiography , 1978 .
[100] R. K. Siegel. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978, NIDA research monograph.
[101] J. F. Cumming,et al. The Development of an Acute Tolerance to Ketamine , 1976, Anesthesia and Analgesia.
[102] G. Corssen,et al. Safety and Tolerance of Repeated Anesthesia with CI 581 (Ketamine) in Monkeys , 1967, Anesthesia and analgesia.